Literature DB >> 32163573

Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.

Yalin Zhao1,2, Yuping Xu3,4,5, Xiaomeng Wang6, Lin Xu6, Jianhua Chen7, Chengwen Gao2, Chuanhong Wu2, Dun Pan7, Qian Zhang2, Juan Zhou7, Ruirui Chen1,2, Zhuo Wang7, Han Zhao8, Li You8, Yunxia Cao3,4,5, Zhiqiang Li1,2,7,9,10, Yongyong Shi1,2,7,9,10.   

Abstract

BACKGROUND: Observational studies have shown a link between elevated body mass index (BMI) and the risk of polycystic ovary syndrome (PCOS). While Mendelian randomization (MR) studies in Europeans have suggested a causal role of increased BMI in PCOS, whether the same role is suggested in Asians has yet to be investigated. We used MR studies to infer causal effects using genetic data from East Asian populations. METHODS AND
FINDINGS: We performed a 2-sample bidirectional MR analysis using summary statistics from genome-wide association studies (GWAS) of BMI (with up to 173 430 individuals) and PCOS (4386 cases and 8017 controls) in East Asian populations. Seventy-eight single nucleotide polymorphisms (SNPs) correlated with BMI were selected as genetic instrumental variables to estimate the causal effect of BMI on PCOS using the inverse-variance weighted (IVW) method. To test the reliability of the results, further sensitivity analyses included MR-Egger regression, weighted median estimates, and leave-one-out analysis. The IVW analysis indicated a significant association between high BMI and the risk of PCOS (odds ratio per standard deviation higher BMI, 2.208; 95% confidence interval 1.537 to 3.168, P = 1.77 × 10-5). In contrast, the genetic risk of PCOS had no significant effect on BMI.
CONCLUSIONS: The results of our bidirectional MR study showed that an increase in BMI causes PCOS, while PCOS does not cause an increased BMI. This study provides further genetic support for a link between BMI and PCOS. Further research is needed to interpret the potential mechanisms of this association. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Mendelian randomization study; body mass index; polycystic ovary syndrome

Mesh:

Substances:

Year:  2020        PMID: 32163573     DOI: 10.1210/clinem/dgaa125

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  A new immunometabolic perspective of intervertebral disc degeneration.

Authors:  Vera Francisco; Jesús Pino; Miguel Ángel González-Gay; Francisca Lago; Jaro Karppinen; Osmo Tervonen; Ali Mobasheri; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2021-11-29       Impact factor: 20.543

Review 2.  Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.

Authors:  Tiantian Zhu; Mark O Goodarzi
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 6.134

3.  Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study.

Authors:  Pomme I H G Simons; Merel E B Cornelissen; Olivier Valkenburg; N Charlotte Onland-Moret; Yvonne T van der Schouw; Coen D A Stehouwer; Stephen Burgess; Martijn C G J Brouwers
Journal:  Clin Endocrinol (Oxf)       Date:  2021-09-15       Impact factor: 3.523

4.  The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study.

Authors:  Hanxiao Chen; Yaoyao Zhang; Shangwei Li; Yuanzhi Tao; Rui Gao; Wenming Xu; Yihong Yang; Kemin Cheng; Yan Wang; Lang Qin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-05       Impact factor: 5.555

Review 5.  Mendelian Randomization: A Review of Methods for the Prevention, Assessment, and Discussion of Pleiotropy in Studies Using the Fat Mass and Obesity-Associated Gene as an Instrument for Adiposity.

Authors:  Fiston Ikwa Ndol Mbutiwi; Tatiana Dessy; Marie-Pierre Sylvestre
Journal:  Front Genet       Date:  2022-02-04       Impact factor: 4.599

6.  Experimentally Induced Hyperinsulinemia Fails to Induce Polycystic Ovary Syndrome-like Traits in Female Rhesus Macaques.

Authors:  Rao Zhou; Cristin M Bruns; Ian M Bird; Joseph W Kemnitz; Daniel A Dumesic; David H Abbott
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

7.  A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study.

Authors:  Huiyu Xu; Guoshuang Feng; Kannan Alpadi; Yong Han; Rui Yang; Lixue Chen; Rong Li; Jie Qiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

8.  Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis.

Authors:  Qianwen Liu; Zhaozhong Zhu; Peter Kraft; Qiaolin Deng; Elisabet Stener-Victorin; Xia Jiang
Journal:  BMC Med       Date:  2022-02-11       Impact factor: 8.775

9.  Genetically Predicted Cigarette Smoking in Relation to Risk of Polycystic Ovary Syndrome.

Authors:  Yingli Tao; Bin Liu; Ying Chen; Yiduoduo Hu; Rui Zhu; Ding Ye; Yingying Mao; Xiaohui Sun
Journal:  Clin Epidemiol       Date:  2021-07-02       Impact factor: 4.790

10.  The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.

Authors:  Pomme I H G Simons; Olivier Valkenburg; Judith A P Bons; Coen D A Stehouwer; Martijn C G J Brouwers
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.